Literature DB >> 6320527

Sera from adult T-cell leukemia patients react with envelope and core polypeptides of adult T-cell leukemia virus.

J Schneider, N Yamamoto, Y Hinuma, G Hunsmann.   

Abstract

Sera from five Japanese patients with adult T-cell leukemia (ATL) showed in the immunofluorescence test for ATL-associated antigen (ATLA) titers ranging from 320 to 1280. Control sera from three healthy adults were negative. These eight sera were used to immunoprecipitate radiolabeled polypeptides from three cell lines infected with adult T-cell leukemia virus (ATLV) and two noninfected human cell lines. Cells were labeled either metabolically with [35S]cysteine, [35S]methionine, or [3H]glucosamine, or chemically with 125-iodine. Immunoprecipitates from cells, virus, and concanavalin A-enriched supernatants were analyzed by polyacrylamide gel electrophoresis. Cells producing ATLV contain gp68, the putative precursor to ATLV envelope polypeptides, gp46, and possibly p15, in addition to several nonglycosylated polypeptides between 40 to 70 kDa. Gp46 is shed into the culture medium and appears to be loosely attached to the viral and cellular surface. After purification on density gradients viral particles contain immunoreactive p24, p19, p15, and small amounts of gp46. Kinetics of synthesis, distribution, size, biochemical characteristics, and immunoreactivity of these polypeptides strongly suggest that most of them are structural components of ATLV or their precursors. Apparently, the intracellular ATLA complex predominantly represents precursors of viral structural polypeptides and gp46 is the viral envelope glycopolypeptide.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6320527     DOI: 10.1016/0042-6822(84)90086-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Multiple sclerosis and human T-cell lymphotropic retroviruses: negative serological results in 135 German patients.

Authors:  J Schneider; B Kitze; G Hunsmann; I Wendler; L Kappos
Journal:  J Neurol       Date:  1987-12       Impact factor: 4.849

Review 2.  The epidemiology of HTLV-I infection.

Authors:  N Mueller
Journal:  Cancer Causes Control       Date:  1991-01       Impact factor: 2.506

3.  Seroepidemiology of human immunodeficiency virus in Africa.

Authors:  I Wendler; J Schneider; B Gras; A F Fleming; G Hunsmann; H Schmitz
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

4.  Peripheral T-lymphocyte activation by human T-cell leukemia virus type I interferes with the CD2 but not with the CD3/TCR pathway.

Authors:  M D Dodon; A Bernard; L Gazzolo
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.

Authors:  S Matsushita; M Robert-Guroff; J Trepel; J Cossman; H Mitsuya; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

6.  Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.

Authors:  Rashade A H Haynes; Andrew J Phipps; Brenda Yamamoto; Patrick Green; Michael D Lairmore
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

7.  The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway.

Authors:  J T Kimata; T J Palker; L Ratner
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Generation, characterization and cross-reactivities of monoclonal antibodies against the p24 core protein and the gp130 envelope glycoprotein of HIV-2ben.

Authors:  A C Faisst; A Otteken; S Nick; G Hunsmann
Journal:  Med Microbiol Immunol       Date:  1993-07       Impact factor: 3.402

9.  Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.

Authors:  Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Glycosylation of the envelope glycoprotein gp130 of simian immunodeficiency virus from sooty mangabey (Cercocebus atys).

Authors:  C Holschbach; J Schneider; H Geyer
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.